OTTAWA (Reuters) – Canada will invest up to C$214 million ($162.8 million) to help develop a domestically made COVID-19 vaccine, and it has secured up to 76 million doses of Quebec City-based Medicago’s potential vaccine, Prime Minister Justin Trudeau said on Friday.
The government will also invest up to C$18.2 million in Vancouver-based biotechnology company Precision NanoSystems Incorporated (PNI) to support a project for pre-clinical and clinical trials for a vaccine.
($1 = 1.3142 Canadian dollars)
(Reporting by Steve Scherer and David Ljunggren; Editing by Chizu Nomiyama)
